|
RNF103 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.624820E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.444800E-03 |
| Normal-vs-Stage2 |
1.004830E-03 |
| Normal-vs-Stage3 |
1.73098999999288E-05 |
| Normal-vs-Stage4 |
2.37329999999147E-05 |
| Stage1-vs-Stage2 |
6.014300E-02 |
| Stage1-vs-Stage3 |
5.476200E-03 |
| Stage1-vs-Stage4 |
1.064090E-02 |
| Stage2-vs-Stage3 |
9.143400E-01 |
| Stage2-vs-Stage4 |
6.745200E-01 |
| Stage3-vs-Stage4 |
6.826400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.381040E-04 |
| Normal-vs-AfricanAmerican |
2.007200E-01 |
| Normal-vs-Asian |
3.396300E-02 |
| Caucasian-vs-AfricanAmerican |
2.561800E-01 |
| Caucasian-vs-Asian |
3.292800E-01 |
| AfricanAmerican-vs-Asian |
7.155400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.187900E-04 |
| Normal-vs-Female |
3.557800E-04 |
| Male-vs-Female |
8.083600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.153600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.85760000000524E-05 |
| Normal-vs-Age(61-80Yrs) |
1.65579999999999E-05 |
| Normal-vs-Age(81-100Yrs) |
7.844100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.579870E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.377300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.194200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.013400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.767800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.154600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.828630E-04 |
| Classical-VS-Follicular |
7.217400E-04 |
| Classical-VS-Other |
3.293200E-01 |
| Classical-VS-Normal |
1.041800E-02 |
| Tall-VS-Follicular |
4.627400E-01 |
| Tall-VS-Other |
5.222400E-01 |
| Tall-VS-Normal |
3.49649999997759E-06 |
| Follicular-VS-Other |
8.716800E-01 |
| Follicular-VS-Normal |
3.9906000000034E-05 |
| Other-VS-Normal |
7.673900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.175900E-04 |
| Normal-vs-N1 |
2.060200E-03 |
| N0-vs-N1 |
9.970600E-01 |
|
|
